期刊文献+

甲状腺乳头状癌浸润前沿磷酸化RB核质转位表达与淋巴结转移相关

Correlation of nuclear-cytoplasmic transport of p RB in the invasive front and lymph node metastasis in papillary thyroid carcinoma
下载PDF
导出
摘要 目的:探讨甲状腺乳头状癌浸润前沿磷酸化RB(p RB)的表达及临床病理意义。方法:用免疫组织化学方法对82例加做颈部淋巴结清扫的部分或全部甲状腺手术切除标本进行p RB检测,分析p RB的表达及临床病理意义。结果:在甲状腺乳头状癌的浸润前沿,可见p RB以核质转位的模式表达,p RB在浸润前沿的核质转位表达是甲状腺乳头状癌淋巴结转移的独立预测因素。结论:浸润前沿p RB核质转位表达是甲状腺乳头状癌淋巴结转移的独立预测因素。 Objective To investigate the expression of phosphorylated RB(p RB) in the invasion front of papillary thyroid carcinoma and the clinical pathological implications. Methods Immunohistochemistry was applied in analyzing p RB expression feature and the clinical pathological implications in a total of 82 patients who underwent total or subtotal thyroidectomy and neck lymph node dissection for papillary thyroid carcinoma. Results The displacement of p RB proteins from the nucleus to the cytoplasm was observed in the invasive front of papillary thyroid carcinoma, which was an independent predictor of lymph node metastasis in papillary thyroid carcinoma. Conclusion Nuclear-cytoplasmic transport of p RB in the invasive front was an independent predictor of lymph node metastasis in papillary thyroid carcinoma.
出处 《实用医学杂志》 CAS 北大核心 2016年第10期1602-1605,共4页 The Journal of Practical Medicine
基金 海南省自然科学基金资助项目(编号:813214) 海南省卫生厅科课题资助项目(编号:琼卫2012PT-15)
关键词 甲状腺肿瘤 乳头状癌 RB 免疫组织化学 核质转位 Thyroid neoplasm Papillary carcinoma RB Immunohistochemistry Nuclearcy-toplasmic transport
  • 相关文献

参考文献13

  • 1肖晓岚,李灼日,解娜,赵青,葛贺锦,吴文川,陈集敏,何艾桦,陈翩.浸润前沿播散性生长方式与甲状腺乳头状癌淋巴结转移相关[J].中华病理学杂志,2015,44(3):204-205. 被引量:4
  • 2LIU Z, KAKUDO K, BAI Y, et al. Loss of cellular polarity/co- hesiveness in the invasive front of papillary thyroid carcinoma, a novel predictor for lymph node metastasis ; possible morpholog- ical indicator of epithelial mesenchymal transition [J]. J Clin Pathol, 2011,64(4) : 325-329.
  • 3JUNG YY, LEE CH, PARK SY, et al. Characteristic tmnor growth patterns as novel histomoqhologic predictors fr lymph node metastasis in papillary thyroid carcinoma [ J ]. Hum Pathol, 2013,44 (12) : 2620-2627.
  • 4CHUNG YJ, LEE JS, PARK SY, et al. Histomot)hological thc-tors in the risk prediction of lymph node metastasis in papillary thyroid earcinoma [J]. Histopathology, 2013,62(4) : 578-588.
  • 5JUNG CK, KANG YG, BAE JS, et al. Unique patterns of tumor growth related with the risk of lymph node metastasis in papillary thyroid carcinoma [J]. Mod Pathol, 2010,23(9) : 1201-1208.
  • 6AGO K, SAEGUSA Y, NISHIMURA J, et al. Involvement of glycogen synthase kinase-3beta signaling and aberrant nucleocy- toplasmic localization of retinoblastoma protein in tumor promo- tion in a rat two-stage thyroid carcinogenesis model [J]. Exp Toxicol Pathol, 2010,62(3 ) : 269-280.
  • 7JIAO W, LIN HM, DATI'A J, et al. Aben'ant nucleocytoplas- mic localization of the retinoblastoma tumor suppressor protein in human cancer correlates with moderate/poor tumor differentia- tion [J]. Oncogene, 2008,27(22) :3156-3164.
  • 8边学,唐平章.人甲状腺乳头状癌与正常腺体组织蛋白质组差异表达分析[J].中华耳鼻咽喉头颈外科杂志,2010,45(4):318-323. 被引量:4
  • 9JIAO W, DATFA J, LIN HM, et al. Nucleocytoplasmic shut-tling of the retinoblastoma tumor suppressor protein via cdk phosphorylation-dependent nuclear export [J]. J Biol Chem, 2006,281 (49) : 38098-38108.
  • 10GRAVINA GL, SENAPEDIS W, MCCAULEY D, et al. Nucleo- cytoplasmic transport as a therapeutic target of cancer [J]. J Hematol Oncol, 2014,7 ( 85 ) : 3-9.

二级参考文献28

  • 1Mazzaferri EL.Management of a solitary thyroid nodule.N Engl J Med,1993,328:553-559.
  • 2Marqusee E,Benson CB.Frates MC,et al.Usefulness of ultrasonography in the management of nodular thyroid disease.Ann Intern Med,2000,133:696-700.
  • 3Haugen BR,Woodmansee WW,McDermott MT.Towards improving the utility of fine-needle aspiration biopsy for the diagnosis of thyroid tumours.Clin Endocrinol(Oxf),2002,56:281-290.
  • 4Ringel MD.Molecular diagnostic tests in the diagnosis and management of thyroid carcinoma.Rev Endoct Metab Disord,2000,1:173-181.
  • 5Hamatani K,Eguchi H,Ito R,et al.RET/PTC rearrangements preferentially occurred in papillary thyroid cancer among atomic bomb survivors exposed to high radiation dose.Cancer Res,2008,68:7176-7182.
  • 6Henderson YC,Shellenberger TD,Williams MD,et al.High rate of BRAF and RET/PTC dual mutations associated with recurrent papillary thyroid carcinoma.Clin Cancer Res,2009,15:485-491.
  • 7lee A,Kim Y,Han K,et al.Detection of tumor markers including caroinocmbryonic antigen,APC,and cyclin D2 in fine-needle aspiration fluid of breast.Arch Pathol Lab Med,2004,128:1251-1256.
  • 8Stradal TB,Gimona M.Ca(2+)-dependent association of S100A6(Calcyclin)with the plasma membrane and the nuclear envelope.J Biol Chem,1999,274:31593-31596.
  • 9Maelandsmo GM,Florenes VA,Mellingsaeter T,et al.Differential expression patterns of S100A2,SIOOA4 and S100A6 during progression of human malignant melanoma.Int J Cancer,1997,74:464-469.
  • 10Brown LM,Helmke SM,Hunsucker SW,et al.Quantitative and qualitative differences in protein expression between papillary thyroid carcinoma and normal thyroid tissue.Mol Carcinog,2006,45:613-626.

共引文献6

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部